PAIA
BSX icon

Park Avenue Institutional Advisers’s Boston Scientific BSX Stock Holding History

Park Avenue Institutional Advisers’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,502
Closed -$199K – 67
2016
Q2 		$199K Buy
8,502
+28
+0.3% +$606 0.17% 141
2016
Q1 		$159K Sell
8,474
-239
-3% -$4.2K 0.14% 173
2015
Q4 		$161K Sell
8,713
-226
-3% -$4.05K 0.14% 179
2015
Q3 		$147K Sell
8,939
-33
-0.4% -$564 0.13% 194
2015
Q2 		$159K Buy
+8,972
New +$160K 0.13% 188

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Park Avenue Institutional Advisers's BSX Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of Boston Scientific (BSX) in Q3 2016, closing a stake of 8,502 shares — an estimated $199K sold.

Park Avenue Institutional Advisers first reported a position in BSX in Q2 2015 and held it in 5 quarters. The position peaked at $199K in Q2 2016. 568 funds tracked by Wall St. Rank hold BSX as of Q3 2016.

  • Park Avenue Institutional Advisers reported no remaining Boston Scientific position as of Q3 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 8,502 Boston Scientific shares in Q3 2016, an estimated $199K.
  • Park Avenue Institutional Advisers first reported a position in Boston Scientific in Q2 2015 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's Boston Scientific position peaked at $199K in Q2 2016.
  • 568 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.